Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationCost of RevenueEBIATLeasesLong-Term Debt IssuancesMachine, Furnitures, Fixtures & OtherNon-Current ReceivablesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - NetReceivables - Other
Ratios

ImmunityBio (IBRX) Shares Repurchased (2016 - 2019)

ImmunityBio (IBRX) has disclosed Shares Repurchased for 4 consecutive years, with $2.0 million as the latest value for Q4 2019.

  • On a quarterly basis, Shares Repurchased rose 777.19% to $2.0 million in Q4 2019 year-over-year; TTM through Dec 2020 was $2.0 million, a 10.23% decrease, with the full-year FY2019 number at $2.5 million, up 996.93% from a year prior.
  • Shares Repurchased was $2.0 million for Q4 2019 at ImmunityBio, up from $228000.0 in the prior quarter.
  • In the past five years, Shares Repurchased ranged from a high of $11.4 million in Q2 2017 to a low of $228000.0 in Q4 2018.
  • A 4-year average of $3.7 million and a median of $2.6 million in 2016 define the central range for Shares Repurchased.
  • Peak YoY movement for Shares Repurchased: crashed 91.77% in 2018, then surged 777.19% in 2019.
  • ImmunityBio's Shares Repurchased stood at $3.9 million in 2016, then dropped by 29.83% to $2.8 million in 2017, then plummeted by 91.77% to $228000.0 in 2018, then surged by 777.19% to $2.0 million in 2019.
  • Per Business Quant, the three most recent readings for IBRX's Shares Repurchased are $2.0 million (Q4 2019), $228000.0 (Q4 2018), and $2.8 million (Q4 2017).